Aptamer Group PLC (AIM: APTA)

Market Cap	7.97M
Revenue (ttm)	860.00K
Net Income (ttm)	-2.96M
Shares Out	1.92B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,735,978
Average Volume	14,124,225
Open	0.430
Previous Close	0.420
Day's Range	0.400 - 0.440
52-Week Range	0.200 - 1.197
Beta	-0.73
RSI	68.94
Earnings Date	Dec 27, 2024

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies. It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company h...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 34
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In 2024, Aptamer Group's revenue was 860,000, a decrease of -50.91% compared to the previous year's 1.75 million. Losses were -2.96 million, -62.25% less than in 2023.